A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin<sup>® </sup>(Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
<p>Abstract</p> <p>Background</p> <p>The management of neovascular age-related macular degeneration (nAMD) has been transformed by the introduction of agents delivered by intravitreal injection which block the action of vascular endothelial growth factor-A (anti-VEGF ag...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-10-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/9/1/56 |